Absence of the JAK2 V617F mutation in patients with arterial thrombosis without overt myeloproliferative disease

J Thromb Haemost. 2008 Sep;6(9):1606-7. doi: 10.1111/j.1538-7836.2008.03081.x. Epub 2008 Jul 12.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Case-Control Studies
  • Female
  • Humans
  • Janus Kinase 2 / genetics*
  • Male
  • Middle Aged
  • Mutation*
  • Myeloproliferative Disorders / genetics*
  • Thrombosis / genetics*

Substances

  • JAK2 protein, human
  • Janus Kinase 2